| Stage | MGTX | % of rev | AMGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $321M | 100.00% | $10.4B | 100.00% | AMGN ×32.25 |
| Gross profit | $314M | 97.77% | $7.6B | 73.10% | MGTX +24.7pp |
| Operating income | $244M | 76.04% | $3.7B | 35.79% | MGTX +40.2pp |
| Pre-tax income | $235M | 73.09% | $4.7B | 45.21% | MGTX +27.9pp |
| Net income | $321M | 99.99% | $3.9B | 37.28% | MGTX +62.7pp |
| Stage | MGTX | AMGN | Gap · A − B |
|---|---|---|---|
| Revenue | $321M100.00% | $10.4B100.00% | AMGN ×32.25 |
| Gross profit | 97.77%$314M | 73.10%$7.6B | MGTX +24.7pp |
| Operating income | 76.04%$244M | 35.79%$3.7B | MGTX +40.2pp |
| Pre-tax income | 73.09%$235M | 45.21%$4.7B | MGTX +27.9pp |
| Net income |
| 99.99%$321M |
| 37.28%$3.9B |
| MGTX +62.7pp |
No shared counterparties.